But a new antibiotic from Swiss pharmaceutical company Roche could change the future of how we treat Gram-negative bacteria. Roche announced on Monday that its antibiotic zosurabalpin will enter phase ...
“Gram-negative bacteria” pose a huge threat to public health. With deathly adaptability, these types of bacteria are able to develop resistance to many antibiotics and survive in a wide range of ...